XC
Exicure, Inc.
XCUR · NASDAQ
$1.25 +1.63% (+$0.02)
1M -7.41%
Market Cap $8.99M
P/E Ratio -
Div. Yield -
ROE 237.91%
Piotroski F-Score Weak
1/9Valuation
0 /100
Expensive P/B 9.20x
P/E N/A
EV/EBITDA N/A
Growth
0 /100
Declining Book val. growth 35.92%
EPS growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
0 /100
Poor ROIC 93.88%
ROE 237.91%
ROA 72.69%
Debt
48 /100
Moderate Debt/Equity 0.00x
Current ratio 0.56x
Int. coverage -8,917.00x
Stability
1 /100
Unstable Beta 3.62x
EPS volatility 181.89%
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o XCUR
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jungsoo Kim
Employees
8
Headquarters
Redwood City
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report